{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:55:39Z","timestamp":1790474139666,"version":"4.1.0"},"reference-count":36,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.3892\/ijo.2014.2584","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T07:18:16Z","timestamp":1407223096000},"page":"1769-1777","source":"Crossref","is-referenced-by-count":26,"title":["Enhanced apoptosis by pemetrexed and simvastatin in malignant mesothelioma and lung cancer cells by reactive oxygen species-dependent mitochondrial dysfunction and Bim induction"],"prefix":"10.3892","volume":"45","author":[{"given":"KI-EUN","family":"HWANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOUNG-SUK","family":"KIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YU-RI","family":"HWANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SU-JIN","family":"KWON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DO-SIM","family":"PARK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BYONG-KI","family":"CHA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BYOUNG-RYUN","family":"KIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KWON-HA","family":"YOON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EUN-TAIK","family":"JEONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAK-RYUL","family":"KIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,8,5]]},"reference":[{"key":"key20180107181549_b1-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"key20180107181549_b2-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1200\/JCO.2004.02.109","article-title":"Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer","volume":"22","author":"Hotta","year":"2004","journal-title":"J Clin Oncol"},{"key":"key20180107181549_b3-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1517\/14728210903074563","article-title":"Malignant pleural mesothelioma: current treatments and emerging drugs","volume":"14","author":"Belli","year":"2009","journal-title":"Expert Opin Emerg Drugs"},{"key":"key20180107181549_b4-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20180107181549_b5-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-na\u00efve patients with advanced-stage non-small-cell lung cancer","volume":"26","author":"Scagliotti","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107181549_b6-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3904\/kjim.2010.25.3.294","article-title":"Pemetrexed versus gefitinib versus erlotinib in previously treated patients with non-small cell lung cancer","volume":"25","author":"Hong","year":"2010","journal-title":"Korean J Intern Med"},{"key":"key20180107181549_b7-ijo-45-04-1769","first-page":"1116","article-title":"LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes","volume":"57","author":"Shih","year":"1997","journal-title":"Cancer Res"},{"key":"key20180107181549_b8-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4046\/trd.2009.67.3.191","article-title":"Efficacy of pemetrexed in relapsed non-small cell lung cancer and thymidylate synthase expression","volume":"67","author":"Park","year":"2009","journal-title":"Tuberc Respir Dis"},{"key":"key20180107181549_b9-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/sj.leu.2404599","article-title":"Pemetrexed acts as an antimyeloma agent by provoking cell cycle blockade and apoptosis","volume":"21","author":"Ramirez","year":"2007","journal-title":"Leukemia"},{"key":"key20180107181549_b10-ijo-45-04-1769","first-page":"2114","article-title":"The impact of p53 status on cellular sensitivity to antifolate drugs","volume":"7","author":"Lu","year":"2001","journal-title":"Clin Cancer Res"},{"key":"key20180107181549_b11-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1158\/1078-0432.CCR-08-1579","article-title":"Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malingnant mesothelioma","volume":"15","author":"Vandermeers","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180107181549_b12-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"key20180107181549_b13-ijo-45-04-1769","first-page":"10","article-title":"The statins as anticancer agents","volume":"9","author":"Chan","year":"2003","journal-title":"Clin Cancer Res"},{"key":"key20180107181549_b14-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nrc1751","article-title":"Statins and cancer prevention","volume":"5","author":"Demierre","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"key20180107181549_b15-ijo-45-04-1769","first-page":"141","article-title":"Synergistic interaction of lovastatin and paclitaxel in human cancer cells","volume":"1","author":"Holstein","year":"2001","journal-title":"Mol Cancer Ther"},{"key":"key20180107181549_b16-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ijc.10440","article-title":"Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism","volume":"100","author":"Feleszko","year":"2002","journal-title":"Int J Cancer"},{"key":"key20180107181549_b17-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.onc.1209117","article-title":"Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signaling","volume":"25","author":"Khanzada","year":"2006","journal-title":"Oncogene"},{"key":"key20180107181549_b18-ijo-45-04-1769","first-page":"1149","article-title":"Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatin","volume":"24","author":"Kozar","year":"2004","journal-title":"Int J Oncol"},{"key":"key20180107181549_b19-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3892\/ijo.2013.1933","article-title":"Synergistic induction of apoptosis by sulindac and simvastatin in A549 human lung cancer cells via reactive oxygen species-dependent mitochondrial dysfunction","volume":"43","author":"Hwang","year":"2013","journal-title":"Int J Oncol"},{"key":"key20180107181549_b20-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jjco\/hyn118","article-title":"Efficacy and toxicity of pemetrexed as a third-line treatment of non-small cell lung cancer","volume":"39","author":"Sun","year":"2009","journal-title":"Jpn J Clin Oncol"},{"key":"key20180107181549_b21-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4143\/crt.2013.45.1.74","article-title":"Interstitial pneumonitis after treatment with pemetrexed for non-small cell lung cancer","volume":"45","author":"Kim","year":"2013","journal-title":"Cancer Res Treat"},{"key":"key20180107181549_b22-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1006\/excr.1998.4380","article-title":"The temporal relationship between protein phosphatase, mitochondrial cytochrome c release","volume":"247","author":"Wolf","year":"1999","journal-title":"Exp Cell Res"},{"key":"key20180107181549_b23-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"key20180107181549_b24-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1104>3.0.CO;2-S","article-title":"Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of human farnesyltransferase, BIM-46228","volume":"91","author":"Prevost","year":"2001","journal-title":"Int J Cancer"},{"key":"key20180107181549_b25-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1007\/s10637-013-0030-0","article-title":"Dual inhibition of MEK 1\/2 and EGFR synergistically induces caspase-3-dependent apoptosis in EGFR inhibitor-resistant lung cancer cells via BIM upregulation","volume":"31","author":"Song","year":"2013","journal-title":"Invest New Drugs"},{"key":"key20180107181549_b26-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.seminoncol.2003.11.006","article-title":"Apotosis in cancer-implications for therapy","volume":"31","author":"Schulze-Bergkamen","year":"2004","journal-title":"Semin Oncol"},{"key":"key20180107181549_b27-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1081\/CNV-120002155","article-title":"Mitochondrial DNA alterations in cancer","volume":"20","author":"Copeland","year":"2002","journal-title":"Cancer Invest"},{"key":"key20180107181549_b28-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4046\/trd.2005.59.1.30","article-title":"Combination treatment with arsenic trioxide and sulindac induces apoptosis of NCI-H157 human lung carcinoma cells via ROS generation with mitochondrial dysfunction","volume":"59","author":"Kim","year":"2005","journal-title":"Tuberc Respir Dis"},{"key":"key20180107181549_b29-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1534-5807(01)00055-7","article-title":"The role of dynamic-related protein 1, a mediator of mitochondrial fission, in apoptosis","volume":"1","author":"Frank","year":"2001","journal-title":"Dev Cell"},{"key":"key20180107181549_b30-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1083\/jcb.200209124","article-title":"Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis","volume":"159","author":"Karbowski","year":"2002","journal-title":"J Cell Biol"},{"key":"key20180107181549_b31-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","volume":"281","author":"Green","year":"1998","journal-title":"Science"},{"key":"key20180107181549_b32-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/35083620","article-title":"Endonuclease G is an apoptotic DNase when released from mitochondria","volume":"412","author":"Li","year":"2001","journal-title":"Nature"},{"key":"key20180107181549_b33-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1126\/science.288.5467.870","article-title":"Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway","volume":"288","author":"Tournier","year":"2000","journal-title":"Science"},{"key":"key20180107181549_b34-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1042\/bst0241028","article-title":"Control of cell proliferation by reactive oxygen species","volume":"24","author":"Burdon","year":"1996","journal-title":"Biochem Soc Trans"},{"key":"key20180107181549_b35-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1476-4598-11-25","article-title":"Molecular mechanism implicated in pemetrexed-induced apoptosis in human melanoma cells","volume":"11","author":"Buque","year":"2012","journal-title":"Mol Cancer"},{"key":"key20180107181549_b36-ijo-45-04-1769","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1038\/sj.onc.1203249","article-title":"More than one way to die: apoptosis, necrosis and reactive oxygen damage","volume":"18","author":"Fiers","year":"1999","journal-title":"Oncogene"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2014.2584\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T15:21:15Z","timestamp":1565709675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2014.2584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,5]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,8,5]]},"published-print":{"date-parts":[[2014,10]]}},"alternative-id":["10.3892\/ijo.2014.2584"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2014.2584","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,5]]}}}